Raymond James & Associates Boston Scientific Corp Call Options Transaction History

Raymond James & Associates

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 08, 2023	BUY	$39.56 - $47.22 $1.03 Million - $1.23 Million	26,000 New	26,000 $1.2 Million
Q2 2022 Aug 12, 2022	SELL	$35.24 - $47.1 $1.09 Million - $1.46 Million	-31,000 Reduced 67.39%	15,000 $2,000
Q1 2022 May 11, 2022	BUY	$40.9 - $45.1 $1.18 Million - $1.3 Million	28,900 Added 169.01%	46,000 $8,000
Q1 2018 May 14, 2018	SELL	$25.2 - $28.54 $70,560 - $79,912	-2,800 Reduced 14.07%	17,100 $162,000
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $9,916 - $11,920	400 Added 2.05%	19,900 $99,000
Q3 2017 Nov 13, 2017	SELL	$26.26 - $29.17 $13,130 - $14,585	-500 Reduced 2.5%	19,500 $182,000
Q2 2017 Aug 14, 2017	BUY	N/A	20,000	20,000 $157,000

1,542

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $131B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.